A New Zealand-developed Covid-19 testing device has just won regulatory approval for use in the United States.
The device was developed by Auckland biotech company Ubiquitome in partnership with Yale University in the United states.
But health authorities in New Zealand are still refusing to approve it for use here.
Ruth Hill reports.
